UNILAG Collaboration With Global Parkinson’s Genetics Program (GP2) Uncovers Genetic Variant

University of Lagos (UNILAG) Researchers uncovers a genetic variant that increases the risk of Parkinson’s Disease.

Researchers from the University of Lagos are key collaborators in the Global Parkinson’s Genetics Program (GP2) that uncovered a genetic variant that increases the risk of Parkinson’s Disease (PD) in Africans and African admixed populations. 

The research finding was the result of teamwork by an international team including the Nigeria Parkinson Disease Research (NPDR) network, the International Parkinson’s Disease Genomics Consortium (IPDGC)-Africa, University College London, the National Institutes of Health (NIH) in the US, and 23andMe. The study was funded by the Michael J Fix foundation for Parkinson’s research and GP2.

MySchoolNews reporting.